Mean residence time in peripheral tissue
Tóm tắt
The published methods for determining the mean residence time for drugs in peripheral tissue are reviewed in terms of assumptions involved, advantages and disadvantages. A method for determining mean transit time in peripheral tissue is proposed; this may be a more useful indicator of the tissue retention properties for drug compounds.
Tài liệu tham khảo
S. Riegelman and P. Collier. The application of statistical moment theory to evaluation ofin vivo dissolution time and absorption time.J. Pharmacokin. Biopharm. 8:509–534 (1980).
K. Yamaoka, T. Nakagawa, and T. Uno. Statistical moments in pharmacokinetics.J. Pharmacokin. Biopharm. 6:547–558 (1978).
L. Z. Benet and R. L. Galeazzi. Noncompartmental determination of the steady-state volume of distribution.J. Pharm. Sci. 68:1071–1074 (1979).
P. Veng-Pedersen and W. Gillespie. Mean residence time in peripheral tissue: a linear disposition parameter useful for evaluating a drug's tissue distribution.J. Pharmacokin. Biopharm. 12:535–543 (1984).
P. Veng-Pedersen and W. Gillespie. The mean residence time of drugs in the systemic circulation.J. Pharm. Sci. 74:791–792 (1985).
J. C. Fleishaker and P. J. McNamara. Performance of a diffusional clearance model forΒ-lactam antimicrobial agents as influenced by extravascular protein binding interstitial fluid kinetics.Antimicrob. Agents Chemother. 28:369–374 (1985).
C. L. DeVane and J. W. Simpkins. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.Drug Metab. Dispos. 13:438–442 (1985).
W. A. Lassen and W. Perl.Tracer Kinetic Methods in Medical Physiology, Raven Press, New York, 1979, p. 98.
M. Gibaldi and D. Perrier.Pharmacokinetics, Marcel Dekker, New York, 1982, pp. 84–88; 232–245.
J. H. Matis and T. E. Wehrly. In M. Rowland, L. B. Sheiner, and T. Steiner (eds.),Variability in Drug Therapy: Description, Estimation, and Control, Raven Press, New York, 1985, pp. 31–50.
J. G. Wagner and co-workers. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.J. Pharmacokin. Biopharm. 5:161–182 (1977).
P. S. Collier. Some considerations on the estimation of steady state apparent volume of distribution and the relationships between volume terms.J. Pharmacokin. Biopharm. 1:93–105 (1983).
J. H. Matis, T. E. Wehrly, and C. M. Metzler. On some stochastic formulations and related statistical moments of pharmacokinetic models.J. Pharmacokin. Biopharm. 11:77–92 (1983).
R. A. Shipley and R. E. Clark.Tracer Methods for In Vivo Kinetics, Theory, and Applications, 1st ed., Academic Press, New York, 1972, pp. 116–118.
L. Z. Benet. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.J. Pharm. Sci. 61:536 (1972).
D. S. Greene, R. Quintilliani, and C. H. Nightingale. Physiological perfusion model for cephalosporin antibiotics. I. Model selection based on blood drug concentrations.J. Pharm. Sci. 67:191–196 (1978).
A. Tsuji, T. Yoshikawa, K. Nishide, H. Minami, M. Kimura, E. Nakashima, T. Terasaki, E. Moyamoto, C. H. Nightingale, and T. Yamana. Physiologically based pharmacokinetic model forΒ-lactam antibiotics, I. Tissue distribution and elimination in rats.J. Pharm. Sci. 72:1239–1252 (1983).
D. M. Ryan, B. Hodges, G. R. Spencer, and S. M. Harding. Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid.Antimicrob. Agents Chemother. 22:995–998 (1982).
P. P. LeBlanc and M. LeBel. Drug distribution in the body: I. Estimation of the rate and extent of distribution using statistical moments.J. Pharm. Belg. 41:69–74 (1986).
P. P. LeBlanc and M. LeBel. Drug distribution in the body: II. Estimation of drug concentration in small anatomic compartments.J. Pharm. Belg. 41:75–82 (1986).
P. Veng-Pedersen and W. R. Gillespie. Single pass mean residence time in peripheral tissues: A distribution parameter intrinsic to the tissue affinity of a drug.J. Pharm. Sci. 75:1119–1126 (1986).